German generic drugs company Stada said on Thursday it had received its third takeover approach, and at 58 euros ($61.89) per share, the latest offer was two euros higher than rival suitor Cinven Partners’ offer.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
